You are here:

Forecasting & Epidemiology

Whatever stage your product is at in the lifecycle and whatever market you are operating in, we have forecasting approaches to meet your needs. Our process is unique; we combine global epidemiology and outcomes data with locally appropriate market research methodologies and world-class proprietary forecasting tools to really drill down into specific segments.

Epidemiology is the starting point for establishing whether you have a strong market for your product. Defining commercially relevant target patient populations requires in-depth knowledge of epidemiology and markets that we offer through our Epi Database® and associated custom services. These services range from highly granular estimates for specific or unusual indications, populations and subsets of populations and data mining around demographic or geographical considerations to customized comorbidity and risk factor analysis, and support for orphan drug and other regulatory submissions.

To find out more, please see our latest white paper on forecasting, read our articles on forecasting in emerged and emerging markets or get in touch.

Case study

Cutting through complexity to offer simple, effective forecasting solutions


Since 2004, our client, a company with pharmaceutical assets, has commissioned ongoing annual forecasts for a portfolio of initially six, now 15, products to support legal reporting and decision-making. The forecasts cover many complex therapy areas including oncology, autoimmune disorders and anti-infectives and are predominantly global forecasts, with regional breakdowns for the EU5, the U.S. and Japan provided separately.